A Mitotic Role for BRCA1/BARD1 in Tumor Suppression?  by Clarke, Paul R. & Sanderson, Helen S.
Leading Edge
PreviewsLoss-of-function germline muta-
tions in BRCA1 or BRCA2 result in an 
increased susceptibility to breast and 
ovarian cancer. Yet it is still not clear 
how BRCA1 and BRCA2 mediate their 
tumor-suppressor activities. Mouse or 
human tumor cells deficient in either 
BRCA1 or BRCA2 exhibit aberrations 
in chromosome structure, including 
translocations, deletions, and fusions 
of multiple chromosomes, suggesting 
that these proteins help to maintain 
chromosomal integrity (Venkitara-
man, 2002). BRCA1 is considered to 
be a caretaker of genome stability, as 
it is involved in homologous recom-
bination during DNA double-
strand-break repair (Venkita-
raman, 2002). BRCA1 is also 
part of the signaling cascade 
that activates the cell-cycle 
checkpoint when DNA dam-
age occurs (Yarden et al., 
2002). Defects in DNA repair 
and DNA damage-response 
checkpoints could readily 
compromise chromosomal 
stability in cells with defec-
tive BRCA1. However, it is 
largely supposition that 
these functions account for 
the main tumor-suppressor 
activity of BRCA1.
BRCA1 exists as a het-
erodimer with BARD1, a pro-
tein to which it is structurally 
related. Both proteins con-
tain a RING domain (present 
in E3 ubiquitin ligases) and 
BRCT motifs that act as spe-
cific phosphopeptide-bind-
ing domains. BRCA1 interacts with 
a variety of other proteins that might 
modulate its biological activity, includ-
ing BRCA2. Additional functions for 
BRCA1 are suggested by its localiza-
tion to centrosomes during mitosis 
(Hsu and White, 1998) and by the find-
ing that BRCA1-defective cells may 
have abnormal numbers of centro-
somes (Sankaran and Parvin, 2006). 
BRCA1 and BARD1 levels increase 
in mitotic cells, and the proteins are 
hyperphosphorylated (Choudhury et 
al., 2005), suggesting that BRCA1/
BARD1 may participate in mitosis, 
thus contributing to the preservation 
of chromosomal integrity. However, 
it is always difficult to assign specific 
mitotic roles to proteins that are also 
important during interphase. In this 
issue of Cell, Joukov et al. (2006) solve 
this dilemma by using Xenopus egg 
extracts to dissect the mitotic function 
of the BRCA1/BARD1 heterodimer.
Spindle assembly can be reca-
pitulated in concentrated extracts 
prepared from the eggs of Xenopus 
laevis, which are arrested in meta-
phase of meiosis II (a mitosis-like 
state). These metaphase extracts 
are an excellent model system for 
dissecting the mitotic role of a pro-
tein from its other effects 
on cell-cycle progression, 
transcription, or DNA repli-
cation. Using such extracts, 
the role of the GTPase Ran 
in microtubule stabiliza-
tion and spindle assembly 
during mitosis has been 
separated from its function 
during interphase, where it 
directs transport of mac-
romolecules between the 
cytoplasm and the nucleus. 
The GTP-bound form of 
Ran (Ran-GTP) is gener-
ated around chromosomes 
by the guanine nucleotide 
exchange factor RCC1 (Fig-
ure 1). Ran-GTP releases 
spindle-assembly factors 
from inhibitory complexes 
with importins, thereby pro-
moting microtubule nucle-
ation, stabilization, and the 
assembly of the spindle 
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The tumor-suppressor protein BRCA1 is thought to act by preserving genomic integrity. 
In this issue of Cell, Joukov et al. (2006) demonstrate that the BRCA1/BARD1 heterodimer 
participates in mitotic spindle assembly, a process conducted by the GTPase Ran. Loss of 
this mitotic function might contribute to tumorigenesis.
Figure 1. Role of the BRCA1/BARD1 Heterodimer in 
Mitotic Spindle Assembly
Ran-GTP generated at chromosomes by RCC1 releases TPX2 
and other spindle-assembly factors from inhibitory complexes 
with importins. TPX2 activates Aurora A kinase, which becomes 
phosphorylated and in turn phosphorylates TPX2. Aurora A also 
phosphorylates BRCA1, although the effect of this phosphoryla-
tion remains unclear. Joukov et al. (2006) propose that BRCA1/
BARD1 regulates correct spindle assembly through the negative 
regulation of XRHAMM, a cofactor for TPX2. Negative regulation 
of XRHAMM would allow TPX2 to become localized to and func-
tion at the spindle poles. It is unclear whether Ran-GTP also di-
rectly regulates BRCA1/BARD1.Cell 127, November 3, 2006 ©2006 Elsevier Inc. 453
around chromosomes (Clarke and 
Zhang, 2001).
In extracts that cycle between 
interphase and mitosis, Joukov et 
al. (2006) observed that BRCA1 and 
BARD1 associate with chromatin 
during interphase and are released 
from chromatin during mitosis. Using 
antibodies generated against BRCA1 
or BARD1, the authors depleted 
these proteins from egg extracts. 
In these cycling extracts, BRCA1/
BRAD1 depletion did not alter the 
timing of cell-cycle progression but 
caused the formation of nuclei that 
were heterogeneous in size. It is not 
clear whether this reflected a failure 
to assemble nuclei of normal size or 
a missegregation of chromosomes 
leading to an irregular complement 
of chromosomes in each nucleus. 
Joukov et al. (2006) interpret their 
finding as evidence for a require-
ment of BRCA1/BARD1 for passage 
through mitosis because a similar 
effect on nuclear assembly is not 
seen in interphase-arrested extracts 
depleted of BRCA1/BARD1.
In Xenopus egg extracts arrested 
in metaphase, depletion of BRCA1/
BARD1 disrupted chromosome con-
gression to the middle of spindles 
formed in vitro. There was a higher 
density of spindle microtubules, but 
they were unfocused at the poles. 
Depletion of BRCA1 and BARD1 
from human HeLa cells using 
small interfering RNAs (siRNAs) 
caused defects in spindle structure 
that were broadly consistent with 
the defects seen in Xenopus egg 
extracts. Strikingly, these defects 
are reminiscent of those induced by 
disrupting RCC1 localization or the 
expression of Ran mutants defective 
in their GTP/GDP cycle (Moore et al., 
2002). Despite such mitotic defects, 
BRCA1/BARD1-deficient cells do 
exit mitosis. However, some lagging 
chromosomes became enclosed in 
separate nuclear envelopes, leading 
to the formation of micronuclei.
To test whether BRCA1/BARD1 
might have a function downstream 
of Ran in spindle assembly, Joukov 
et al. (2006) examined the effects 
of BRCA1/BARD1 depletion on the 
formation of microtubule asters that 454 Cell 127, November 3, 2006 ©2006 Eform upon addition of exogenous 
Ran-GTP. The asters that assem-
bled in BRCA1/BARD1-depleted 
extracts were larger, with poorly 
focused microtubules. To under-
stand how BRCA1/BARD1 might 
function in this assay, Joukov et al. 
(2006) examined the localization 
of four potential effectors—NuMA, 
γ-tubulin, TPX2, and XRHAMM—in 
BRCA1/BARD1-depleted Xenopus 
extracts. Although the accumulation 
of NuMA at aster poles seemed nor-
mal, γ-tubulin and XRHAMM local-
ization was more diffuse, and TPX2 
became localized along the length 
of microtubules instead of at the 
poles. Importantly, Ran-dependent 
aster formation and the polar local-
ization of TPX2 were fully restored 
by addition of recombinant BRCA1/
BARD1, but not by a BRCA1/BARD1 
heterodimer defective in its ubiqui-
tin ligase activity. Similarly, centro-
some-dependent aster formation 
and spindle assembly were also dis-
organized by depletion of BRCA1/
BARD1, and TPX2 failed to con-
centrate at each pole. Comparable 
effects on TPX2 localization were 
found when BRCA1 and BARD1 were 
depleted from HeLa cells by siRNA. 
Immunoprecipitation revealed an 
interaction between BRCA1/BARD1 
and XRHAMM, NuMA, and TPX2 
that was not mediated by microtu-
bules. Additional experiments dem-
onstrated that XRHAMM is hyper-
active in BRCA1/BARD1-depleted 
extracts and that this hyperactivity 
causes the mislocalization of TPX2 
and aberrant spindle assembly. Jou-
kov et al. (2006) suggest that ubiq-
uitination of XRHAMM by BRCA1/
BARD1 may contribute to the proper 
localization of TPX2 to the poles.
The study by Joukov et al. (2006) 
provides clear evidence that BRCA1/
BARD1 has a distinct role in mitosis. 
These results are in broad agree-
ment with previous work by San-
karan et al. (2005), who found that 
siRNA-mediated depletion of BRCA1 
increased microtubule nucleation 
at centrosomes, whereas excess 
BRCA1 inhibited aster formation in 
Xenopus egg extracts. Joukov et al. 
(2006) propose that BRCA1/BARD1 lsevier Inc.acts through established spindle-
assembly factors to control the 
proper organization of microtubules 
(Figure 1). Given that TPX2 also 
interacts with the oncogenic kinase 
Aurora A, which phosphorylates 
BRCA1, as well as HURP (hepato-
carcinoma-upregulated protein), a 
network of interactions orchestrated 
by Ran-GTP seems to be emerging 
that controls mitotic spindle assem-
bly and is disrupted in cancer (Sand-
erson and Clarke, 2006).
The new work poses a number of 
questions regarding the mechanism 
and significance of these findings 
for understanding the tumor-sup-
pressor function of BRCA1. First, 
how does the BRCA1/BARD1 dimer 
control XRHAMM and TPX2, and 
what is the role of its ubiquitin ligase 
activity? Perhaps BRCA1/BARD1 
is involved in the precise spatial 
regulation of the activity of spin-
dle-assembly factors through local 
inhibition of XRHAMM. BRCA1 has 
been found concentrated at cen-
trosomes (Hsu and White, 1998), 
although this localization has not 
been confirmed by Joukov et al. 
(2006). Second, what is the rela-
tionship between BRCA1/BARD1 
and Ran? Although BRCA1/BARD1 
seems to act downstream of Ran, 
it is not clear whether it works in 
parallel with the activation of spin-
dle-assembly factors by Ran-GTP 
or whether BRCA1/BARD1 itself is 
regulated by Ran. Both BRCA1 and 
BARD1 have been found to move 
between the nucleus and cyto-
plasm during interphase, and they 
contain nuclear import and export 
motifs that could also interact with 
Ran effectors during mitosis. Third, 
how much do the effects on the 
localization of XRHAMM, TPX2, and 
perhaps NuMA account for the role 
of BRCA1/BARD1 in mitotic spindle 
assembly? Other studies have indi-
cated that BRCA1 may also catalyze 
the ubiquitination of centrosomal 
components including γ-tubulin and 
therefore might have more direct 
effects on centrosome function 
(Sankaran and Parvin, 2006; San-
karan et al., 2005). More generally, 
to what extent does the function of 
BRCA1/BARD1 in mitotic spindle 
assembly account for chromo-
somal instability when its function 
is compromised, and how does this 
relate to the development of tissue-
specific tumors? Given that breast 
and ovarian tumors are two of the 
most common forms of cancer and 
account for a substantial number of 
cancer-related deaths in women, 
answers to these questions are of 
vital interest to more than just cell 
biologists.All growing cells replicate their DNA 
during each cell cycle. Although 
there are multiple mechanisms to 
ensure fidelity by the replicative DNA 
polymerases, the process is still 
perilous. The template strands may 
contain lesions associated with the 
stalling of replication or may suffer 
more severe damage leading to the 
collapse of replication forks. These 
lesions associated with replication 
stalling are usually bypassed by 
translesion DNA polymerases that 
can accommodate modified bases 
in the template DNA. Another pro-
posed mechanism for lesion bypass 
is template switching, a process in 
which the nascent sister strands 
pair and one is used as the template 
for synthesis of the stalled strand 
past the lesion (Figure 1).
Replication-fork reversal occurs 
when the checkpoint for DNA rep-
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DNA synthesis, presumably to sta-
bilize the replication forks that stall 
under routine conditions and to aid 
the recruitment of repair factors 
(Shechter et al., 2004). Branzei et al. 
(2006) now report that sumoylation 
helps to prevent the accumulation 
of these cruciform structures at 
stalled forks.
When fork progression is retarded—
for example, by limiting deoxyribo-
nucleotides, introducing defective DNA 
polymerases, or reducing amounts of a 
replicative polymerase (Kokoska et al., 
2000)—single-strand regions accumu-
late at the replication forks and recom-
bination is increased in genetic assays. 
Single-strand DNA can be recombino-
genic, as it is a target for the binding of 
Rad51 recombinase. It is also subject 
to breakage that can lead to the forma-
tion of recombinogenic double-strand 
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orks.
